1/51
Comprehensive vocabulary flashcards covering the hematology and general physiology lecture on body fluid compartments, homeostasis, plasma proteins, erythrocytes, hemoglobin synthesis, iron metabolism, anemias, platelet biology, and hemostasis.
Total Body Water (TBW)
Constitutes approximately 60% of total body weight in an adult male, less than 60% in adult females and obese individuals due to higher fat content, and 75% in infants.
Intracellular Fluid (ICF) Compartment
Water contained inside cells, representing 32 of total body water and 40% of total body weight.

Extracellular Fluid (ECF) Compartment
Water situated outside cells, accounting for 31 of total body water and 20% of total body weight; subdivided into interstitial fluid (15% of body weight) and intravascular fluid (5% of body weight).
Fick's Principle (Indicator Dilution Method)
A technique to measure compartment volume by injecting a known amount of an inert, non-toxic indicator intravenously and dividing by its plasma concentration: Volume of compartment=Concentration in plasmaKnown amount of substance injected IV.
Homeostasis
The maintenance of a constant internal environment, especially the interstitial fluid (ISF) surrounding cells, regulated by most body systems to stabilize gases, nutrients, ions, pH, and temperature.
Negative Feedback
The most common regulatory mechanism in homeostasis, wherein the control center initiates responses that reverse the detected deviation to return a variable back to its ideal state.
Positive Feedback
A control mechanism that progressively amplifies the output of the control center to accelerate a process toward rapid completion, such as uterine contractions during birth and blood clotting.

Arterial Blood vs. Venous Blood Color
Arterial blood is scarlet red due to containing higher levels of O2, whereas venous blood is purple-red due to containing more CO2.
Serum
The fluid remaining after blood clots in a glass tube, consisting of plasma minus fibrinogen and other coagulation factors.
Albumin/Globulin (A/G) Ratio
The physiological ratio of plasma albumin to globulin, normally 1.2–1.6, which decreases in liver diseases, renal diseases, and infections.
Colloidal Osmotic Pressure (Oncotic Pressure)
An effective osmotic pressure of 25–28mmHg exerted by plasma proteins (chiefly albumin) across impermeable capillary membranes, which draws tissue fluid into blood and maintains circulating blood volume.
Blood Viscosity
The internal resistance to flow; whole blood is 3 times as viscous as water (caused primarily by RBCs), whereas plasma is 1.5 times as viscous as water (caused primarily by elongated fibrinogen molecules).
Erythrocyte (RBC)
A circular, biconcave, non-nucleated disc lacking mitochondria and ribosomes, specialized in O2 and CO2 transport with a lifespan of 120days.
Hematocrit Value
The ratio of red blood cell volume to total blood volume, normally averaging 46% in males and 42% in females.

Adult Hemoglobin (HbA)
The predominant hemoglobin type in adults (96–98%), composed of four polypeptide chains arranged as α2β2, each bound to a heme group containing Fe2+.
Fetal Hemoglobin (HbF)
A hemoglobin variant (α2γ2) with a higher oxygen affinity than HbA, facilitating oxygen extraction from maternal circulation; completely replaced by HbA by 4months after birth.
Oxyhemoglobin (HbO2)
The reversible combination of hemoglobin with molecular oxygen, where O2 binds loosely to Fe2+ without causing chemical oxidation (oxygenation only).
Carbaminohemoglobin (HbCO2)
The compound formed when carbon dioxide chemically attaches directly to the globin polypeptide chains of the hemoglobin molecule.
Carboxyhemoglobin (HbCO)
A stable complex formed by the high-affinity binding of carbon monoxide (CO) to hemoglobin, which strongly blocks oxygen transport.
Methemoglobin (MetHb)
An oxidized form of hemoglobin where ferrous iron (Fe2+) is converted to ferric iron (Fe3+) by strong oxidizing agents, rendering it dark-colored and incapable of transporting oxygen.
NADH Methemoglobin Reductase
The intracellular enzyme responsible for reducing small amounts of methemoglobin back to functional hemoglobin; its deficiency results in hereditary methemoglobinemia.

Erythropoiesis
The physiological process of red blood cell formation, progressing from hemocytoblasts through proerythroblasts, late erythroblasts, normoblasts, and reticulocytes to mature erythrocytes.
Erythropoietin
A glycoprotein hormone produced primarily by the kidneys (85%) and liver (15%) in adults (almost completely by the liver in fetuses) that accelerates all stages of erythropoiesis in response to tissue hypoxia.
Ferritin
The primary intracellular storage protein for iron found inside liver cells, the spleen, intestinal enterocytes, and bone marrow; aggregates can coalesce to form hemosiderin.
Divalent Metal Transporter 1 (DMT1)
The apical transport protein in duodenal enterocytes responsible for absorbing non-heme iron in its reduced ferrous (Fe2+) state.
Ferroportin
A basolateral iron exporter on enterocytes, macrophages, and hepatocytes that releases Fe2+ into the bloodstream where it is oxidized by ferroxidase to Fe3+.
Hepcidin
A 25-amino-acid peptide hormone synthesized by the liver that inhibits intestinal iron absorption and macrophage release by binding, internalizing, and degrading ferroportin.
Intrinsic Factor (IF)
A protective glycoprotein secreted by gastric parietal cells that binds dietary vitamin B12 and enables its receptor-mediated endocytosis in the brush border of the lower ileum in the presence of trypsin.
Anemia
A reduction in the oxygen-carrying capacity of blood caused by a decreased number or dysfunction of RBCs, defined as RBC count <4.5×106/μL (Hb<13.5g/dL) in males and <3.9×106/μL (Hb<11.5g/dL) in females.
Normocytic Normochromic Anemia
Anemia characterized by reduced total RBC mass and hemoglobin concentration while MCV (80–100fL) and MCH remain within normal limits; caused by bone marrow depression, acute blood loss, or hemolysis.
Microcytic Hypochromic Anemia
Anemia featuring small, pale erythrocytes with MCV<80μ3 and MCH<25pg, most frequently caused by iron deficiency (dietary lack, malabsorption, or chronic blood loss).

Macrocytic (Megaloblastic) Anemia
Anemia characterized by abnormally large, fragile red cells with MCV>95μ3 (>100fL) resulting from impaired DNA synthesis and nuclear maturation due to vitamin B12 or folic acid deficiency.
Pernicious Anemia
A familial autoimmune disease marked by immune destruction of gastric parietal cells, causing absence of gastric HCl and intrinsic factor, leading to vitamin B12 malabsorption, macrocytic anemia, and neuropathy.
Polycythemia Vera (Primary Polycythemia)
A myeloproliferative disorder of RBC-forming organs that elevates erythrocyte counts up to 6–8×106/mm3, typically accompanied by increased WBC and platelet production.
Secondary Polycythemia
An adaptive increase in circulating red blood cells occurring in response to tissue hypoxia, such as in obstructive pulmonary diseases or acclimatization to high altitudes.
Platelet (Thrombocyte)
A small (2–4μm), non-nucleated cell fragment derived from marrow megakaryocytes under the influence of thrombopoietin, with a normal circulating count of 200,000–400,000/mm3 and an 8-day lifespan.
Hemostasis
The physiological arrest of bleeding following vascular injury, encompassing vascular constriction, primary platelet plug formation, secondary coagulation clot formation, and eventual clot dissolution and tissue repair.

Platelet Activation Stages
The sequential functional transitions of platelets following endothelial disruption, comprising adhesion (Stage 1), granular secretion (Stage 2), and aggregation into a mechanical plug (Stage 3).
Von-Willebrand Factor (vWF)
An endothelial-derived plasma glycoprotein present in subendothelial matrix and complexed with Factor VIII in circulation that anchors platelets to exposed subendothelial collagen during adhesion.
Thromboxane A2 (TXA2)
A potent metabolite synthesized from arachidonic acid by platelet cyclooxygenase that acts as a strong vasoconstrictor, induces granular release, and powerfully stimulates platelet aggregation.

Prostacyclin (PGI2)
An eicosanoid synthesized from arachidonic acid by vascular endothelial cyclooxygenase that causes vasodilation and inhibits platelet aggregation, thereby confining clot formation to the site of injury.
Fibrinogen Group
A functional category of clotting factors comprising Factors I (fibrinogen), V, VIII, and XIII, all of which are consumed during clotting and activated by thrombin.
Prothrombin Group
A cluster of clotting factors comprising Factors II (prothrombin), VII, IX, and X, which require vitamin K for their hepatic post-translational carboxylation.
Contact Group
The initial factors of the intrinsic clotting cascade, consisting of Factors XI and XII, which undergo activation upon exposure to electronegatively charged wettable surfaces or subendothelial collagen.

Clotting Cascade
The sequential enzymatic activation of plasma proenzymes through intrinsic and extrinsic pathways that converge onto Factor X activation, driving thrombin generation and the conversion of fibrinogen to a cross-linked fibrin mesh.
Thrombomodulin
An endothelial surface receptor that complexes with circulating thrombin to activate Protein C, which, alongside Protein S, proteolytically inactivates Factors Va and VIIIa and neutralizes tPA inhibitors.
Heparin vs. Dicumarol
Heparin acts rapidly in vivo and in vitro by facilitating antithrombin III-mediated inhibition of Factors IXa, Xa, XIa, and XIIa (antidote: protamine sulfate 1%); Dicumarol acts slowly only in vivo via competitive inhibition of vitamin K (antidote: vitamin K).
Thrombocytopenic Purpura
A bleeding diathesis resulting from a low platelet count (<50,000/mm3) or thrombasthenia, marked by petechial subcutaneous hemorrhages and a prolonged bleeding time with normal clotting time.
Hemophilia A
An X-linked recessive bleeding disorder accounting for 85% of hemophilia cases, caused by a congenital deficiency of Factor VIII and characterized by hemarthroses, deep tissue bleeding, and a prolonged clotting time.
Disseminated Intravascular Coagulation (DIC)
A severe acquired thrombo-hemorrhagic syndrome triggered by massive systemic release of tissue thromboplastin (e.g., in septicemia, shock, or retained dead fetus), leading to widespread microvascular thrombosis and consumption coagulopathy.
Bleeding Time vs. Coagulation Time
Bleeding time (1–3mins) assesses capillary constriction and platelet plug efficiency; coagulation time (3–10mins) measures the time required for whole blood to form a definitive fibrin clot via intrinsic enzymatic pathways.

Erythroblastosis Fetalis
Hemolytic disease of the newborn occurring when an Rh− mother sensitized by fetal Rh+ blood produces maternal anti-D (IgG) antibodies that cross the placenta in subsequent pregnancies, causing fetal hemolysis, severe jaundice, and kernicterus.